PERRIGO Co plcPRGO

NYSEHealthcarePharmaceutical Preparations
Price (close)
$14.68
Market cap
$2.0B
P/E
—
Revenue (TTM)
$4.1B
Net income
-$1.7B
Dividend yield
5.93%
1-year total return
-24.3%
Net margin
-41.9%
Revenue growth
-4.2%
Debt / equity
1.31x

What PERRIGO Co plc does.

Perrigo Company plc was incorporated under the laws of Ireland on June 28, 2013 and became the successor registrant of Perrigo Company, a Michigan corporation, on December 18, 2013 in connection with the acquisition of Elan Corporation, plc ("Elan"). Unless the context requires otherwise, the terms "Perrigo," the "Company," "we," "our," "us," and similar pronouns used herein refer to Perrigo Company plc, its subsidiaries, and all predecessors of Perrigo Company plc and its subsidiaries.

Perrigo is a leading pure-play self-care company with more than a century of providing high-quality health and wellness solutions to meet the evolving needs of consumers. As one of the originators of the over-the-counter ("OTC") self-care market, Perrigo is led by its vision "To Provide The Best Self-Care For Everyone" and its purpose to "Make Lives Better Through Trusted Health and Wellness Solutions, Accessible To All".

Perrigo works to fulfill its vision and purpose as a top-tier consumer self-care company with a focused portfolio based on consumer-led innovation, which meets societal needs for:

Revenue and profit, by fiscal year.

Fiscal year202020212022202320242025
Revenue$4.1B$4.1B$4.5B$4.7B$4.4B$4.3B
Net income-$162.6M-$68.9M-$140.6M-$12.7M-$171.8M-$1.4B
Free cash flow$465.8M$4.2M$210.9M$303.8M$244.6M$145.1M

More on PRGO.

Figures from PERRIGO Co plc's filings with the U.S. SEC, standardised automatically; prices are end-of-day closes. Not financial advice.